Literature DB >> 10667719

II: Ex vivo viability testing of kidneys after postmortem warm ischemia.

B M Stubenitsky1, M M Booster, L Brasile, E M Green, C E Haisch, H K Singh, R W Jacobs, G Kootstra.   

Abstract

Future approaches to expand the organ donor pool with marginal and nonheartbeating donors, will be dependent upon prospective organ evaluation. Restoration of metabolism by preservation at warmer temperatures could potentially provide the window for such evaluation. Using a small bovine model, kidneys were subjected to either < 15, < 30 or < 60 minutes of warm ischemia (WI) followed by cold ischemia (CI) in ViaSpan. After WI and CI, kidneys were transitioned to a warm temperature perfusion (30 degrees C to 32 degrees C) using exsanguinous metabolic support (EMS) technology. Restored renal metabolism and function was assessed by oxygen consumption, glucose consumption, urine production, glomerular filtration rate, and hemodynamic characteristics. The results of this study suggest that it is feasible to distinguish viable from nonviable organs ex vivo by assessing renal metabolism and function during warm preservation using EMS technology.

Entities:  

Mesh:

Year:  2000        PMID: 10667719     DOI: 10.1097/00002480-200001000-00017

Source DB:  PubMed          Journal:  ASAIO J        ISSN: 1058-2916            Impact factor:   2.872


  3 in total

1.  Continuous real-time viability assessment of kidneys based on oxygen consumption.

Authors:  B P Weegman; V A Kirchner; W E Scott; E S Avgoustiniatos; T M Suszynski; J Ferrer-Fabrega; M D Rizzari; L S Kidder; R Kandaswamy; D E R Sutherland; K K Papas
Journal:  Transplant Proc       Date:  2010 Jul-Aug       Impact factor: 1.066

2.  A stirred microchamber for oxygen consumption rate measurements with pancreatic islets.

Authors:  Klearchos K Papas; Anna Pisania; Haiyan Wu; Gordon C Weir; Clark K Colton
Journal:  Biotechnol Bioeng       Date:  2007-12-01       Impact factor: 4.530

Review 3.  Islet assessment for transplantation.

Authors:  Klearchos K Papas; Thomas M Suszynski; Clark K Colton
Journal:  Curr Opin Organ Transplant       Date:  2009-12       Impact factor: 2.640

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.